|
Multiple sclerosis
Citations 31-40 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- CLINICAL/SCIENTIFIC NOTES
INTERFERON BETA TREATMENT DOES NOT INDUCE ORGAN-SPECIFIC AUTOANTIBODIES IN MULTIPLE SCLEROSIS
- T. Menge, N. C. Schloot, M. Schott, B. Hemmer, H. Wiendl, M. Roden, H. -P. Hartung, and B. C. Kieseier
Neurology 2009; 73: 900-902.
[Full text]
[PDF]
- ARTICLES
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis
- Anna K. Hedström, Maria Bäärnhielm, Tomas Olsson, and Lars Alfredsson
Neurology 2009; 73: 696-701.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Transcranial sonography of deep gray nuclei. A new outcome measure in multiple sclerosis?
- Istvan Pirko and Robert Zivadinov
Neurology first published on August 26, 2009 as doi: WNL.0b013e3181bb1de9.
Rapid PDF
- EDITORIALS
Multiple sclerosis: Evidence of maternal effects and an increasing incidence in women
- John W. Rose
Neurology 2009; 73: 578-579.
[Full text]
[PDF]
- ARTICLES
Parent-of-origin effect in multiple sclerosis: Observations from interracial matings
- S. V. Ramagopalan, I. M. Yee, D. A. Dyment, S. -M. Orton, R. A. Marrie, A. D. Sadovnick, G. C. Ebers For the Canadian Collaborative Study Group
Neurology 2009; 73: 602-605.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
What you see depends on how you look. Gray matter lesions in multiple sclerosis
- Declan T. Chard and David H. Miller
Neurology first published on August 19, 2009 as doi: WNL.0b013e3181b99a1e.
Rapid PDF
- EDITORIALS
Benign or not benign MS: A role for routine neuropsychological assessment?
- Ralph H.B. Benedict and Franz Fazekas
Neurology 2009; 73: 494-495.
[Full text]
[PDF]
- ARTICLES
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis
- E. Portaccio, M. L. Stromillo, B. Goretti, V. Zipoli, G. Siracusa, M. Battaglini, A. Giorgio, M. L. Bartolozzi, L. Guidi, S. Sorbi, A. Federico, M. P. Amato, and N. De Stefano
Neurology 2009; 73: 498-503.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis
- R. Zivadinov, B. Weinstock-Guttman, K. Hashmi, N. Abdelrahman, M. Stosic, M. Dwyer, S. Hussein, J. Durfee, and M. Ramanathan
Neurology 2009; 73: 504-510.
[Abstract]
[Full text]
[PDF]
- VIEWS AND REVIEWS
The challenge of follow-on biologics for treatment of multiple sclerosis
- S. C. Reingold, J. P. Steiner, C. H. Polman, J. A. Cohen, M. S. Freedman, L. Kappos, A. J. Thompson, and J. S. Wolinsky
Neurology 2009; 73: 552-559.
[Abstract]
[Full text]
[PDF]
|
|
